Vasoactive intestinal peptide (RTP Pharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVasoactive intestinal peptide (RTP Pharma)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionVasoactive intestinal peptide receptor agonists

TargetsVasoactive intestinal peptide receptor

Therapy Area/IndicationsEsophageal Achalasia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSkyepharma Ag

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSkyepharma Ag

Active IndicationsN/A

Inactive IndicationsEsophageal Achalasia

ATC CodeN/A